ISS Backs Dynavax Technologies' Director Nominees Ahead of June 2025 Shareholder Meeting

Reuters

昨天

ISS Backs Dynavax Technologies' Director Nominees Ahead of June 2025 Shareholder Meeting

Dynavax Technologies Corporation, a biopharmaceutical company known for its innovative vaccines, has received a recommendation from Institutional Shareholder Services (ISS), a leading independent proxy advisory firm, urging stockholders to vote "FOR" all four of the company's director nominees in the upcoming Annual Meeting of Stockholders scheduled for June 11, 2025. The nominees include Brent MacGregor, Scott Myers, Lauren Silvernail, and Elaine Sun. ISS has recognized Dynavax's current board as being best equipped to deliver long-term stockholder value, countering a campaign by Deep Track, which ISS claims could harm long-term value. Dynavax has emphasized the importance of each vote and is encouraging stockholders to use the GOLD proxy card to support the recommended nominees. The company has enlisted Goldman Sachs & Co. LLC as its financial advisor and Cooley LLP as legal counsel.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dynavax Technologies Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: SF95412) on May 23, 2025, and is solely responsible for the information contained therein.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2537156202"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2537156202\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2537156202?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-24 01:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2537156202","market":"us","top_or_hot":-1,"title":"ISS Backs Dynavax Technologies' Director Nominees Ahead of June 2025 Shareholder Meeting","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      ISS Backs Dynavax Technologies' Director Nominees Ahead of June 2025 Shareholder Meeting\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Dynavax Technologies Corporation, a biopharmaceutical company known for its innovative vaccines, has received a recommendation from Institutional Shareholder Services (ISS), a leading independent proxy advisory firm, urging stockholders to vote \"FOR\" all four of the company's director nominees in the upcoming Annual Meeting of Stockholders scheduled for June 11, 2025. The nominees include Brent MacGregor, Scott Myers, Lauren Silvernail, and Elaine Sun. ISS has recognized Dynavax's current board as being best equipped to deliver long-term stockholder value, countering a campaign by Deep Track, which ISS claims could harm long-term value. Dynavax has emphasized the importance of each vote and is encouraging stockholders to use the GOLD proxy card to support the recommended nominees. The company has enlisted Goldman Sachs &amp; Co. LLC as its financial advisor and Cooley LLP as legal counsel.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dynavax Technologies Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: SF95412) on May 23, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>ISS Backs Dynavax Technologies' Director Nominees Ahead of June 2025 Shareholder Meeting</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nISS Backs Dynavax Technologies' Director Nominees Ahead of June 2025 Shareholder Meeting\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-05-24 01:44</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      ISS Backs Dynavax Technologies' Director Nominees Ahead of June 2025 Shareholder Meeting\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Dynavax Technologies Corporation, a biopharmaceutical company known for its innovative vaccines, has received a recommendation from Institutional Shareholder Services (ISS), a leading independent proxy advisory firm, urging stockholders to vote \"FOR\" all four of the company's director nominees in the upcoming Annual Meeting of Stockholders scheduled for June 11, 2025. The nominees include Brent MacGregor, Scott Myers, Lauren Silvernail, and Elaine Sun. ISS has recognized Dynavax's current board as being best equipped to deliver long-term stockholder value, countering a campaign by Deep Track, which ISS claims could harm long-term value. Dynavax has emphasized the importance of each vote and is encouraging stockholders to use the GOLD proxy card to support the recommended nominees. The company has enlisted Goldman Sachs &amp; Co. LLC as its financial advisor and Cooley LLP as legal counsel.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dynavax Technologies Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: SF95412) on May 23, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250523:nNDL8CzTVw:1","article_id":"2537156202","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2537156202","pubTimestamp":1748022271,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Dynavax Technologies Corporation, a biopharmaceutical company known for its innovative vaccines, has received a recommendation from Institutional Shareholder Services , a leading independent proxy advisory firm, urging stockholders to vote \"FOR\" all four of the company's director nominees in the upcoming Annual Meeting of Stockholders scheduled for June 11, 2025. The nominees include Brent MacGregor, Scott Myers, Lauren Silvernail, and Elaine Sun. ISS has recognized Dynavax's current board as being best equipped to deliver long-term stockholder value, countering a campaign by Deep Track, which ISS claims could harm long-term value. Dynavax has emphasized the importance of each vote and is encouraging stockholders to use the GOLD proxy card to support the recommended nominees. The company has enlisted Goldman Sachs & Co. LLC as its financial advisor and Cooley LLP as legal counsel.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"ISS在2025年6月股东大会之前支持Dynavax Technologies的董事提名","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DVAX":0.9},"content_text":"ISS Backs Dynavax Technologies' Director Nominees Ahead of June 2025 Shareholder Meeting\n    \n\n        Dynavax Technologies Corporation, a biopharmaceutical company known for its innovative vaccines, has received a recommendation from Institutional Shareholder Services (ISS), a leading independent proxy advisory firm, urging stockholders to vote \"FOR\" all four of the company's director nominees in the upcoming Annual Meeting of Stockholders scheduled for June 11, 2025. The nominees include Brent MacGregor, Scott Myers, Lauren Silvernail, and Elaine Sun. ISS has recognized Dynavax's current board as being best equipped to deliver long-term stockholder value, countering a campaign by Deep Track, which ISS claims could harm long-term value. Dynavax has emphasized the importance of each vote and is encouraging stockholders to use the GOLD proxy card to support the recommended nominees. The company has enlisted Goldman Sachs & Co. LLC as its financial advisor and Cooley LLP as legal counsel.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dynavax Technologies Corporation published the original content used to generate this news brief via PR Newswire (Ref. ID: SF95412) on May 23, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}